Which feature best distinguishes alternative splicing from constitutive splicing in eukaryotic gene expression?

Explanation

## Alternative Splicing vs Constitutive Splicing ### Fundamental Distinction **Key Point:** The defining feature of alternative splicing is the **variable inclusion or exclusion of exons**, resulting in multiple distinct mRNA and protein isoforms from a single gene. Constitutive splicing always removes the same introns and includes the same exons in every transcript. ### Comparative Table | Feature | Constitutive Splicing | Alternative Splicing | |---------|----------------------|----------------------| | **Exon inclusion pattern** | Always the same | Variable (exons included or skipped) | | **mRNA isoforms produced** | One | Multiple (2–10+) | | **Protein diversity** | Single protein | Multiple protein variants | | **Spliceosome machinery** | Standard snRNPs (U1, U2, U4, U5, U6) | Same snRNPs + SR proteins and regulatory factors | | **Intron removal** | Yes, always | Yes, but pattern varies | | **GU-AG rule** | Followed | Followed | | **Regulation** | Constitutive (housekeeping genes) | Tissue-specific, developmental, stress-responsive | ### Mechanisms of Alternative Splicing 1. **Exon skipping/inclusion** — most common; entire exons included or excluded 2. **Alternative 5' splice site** — different 5' splice sites used 3. **Alternative 3' splice site** — different 3' splice sites used 4. **Intron retention** — intron remains in mature mRNA 5. **Mutually exclusive exons** — only one exon from a group is included ### Regulatory Factors **High-Yield:** Alternative splicing is regulated by: - **SR proteins** (serine/arginine-rich) — promote splicing - **hnRNPs** (heterogeneous nuclear ribonucleoproteins) — inhibit splicing - **Tissue-specific factors** — determine which isoforms are made in different cell types - **RNA secondary structure** — can mask or expose splice sites **Clinical Pearl:** ~95% of human multi-exon genes undergo alternative splicing. Mutations affecting splice sites or regulatory elements can cause disease by altering the splicing pattern (e.g., β-thalassemia, spinal muscular atrophy). ### Diagram: Alternative Splicing Mechanism ```mermaid flowchart TD A[Pre-mRNA with exons 1-4 and introns]:::outcome --> B{Splice site recognition}:::decision B -->|Constitutive| C[Remove introns 1, 2, 3<br/>Include exons 1-4]:::action B -->|Alternative| D{Regulatory factors<br/>present?}:::decision D -->|SR proteins dominant| E[Include exon 3<br/>Remove introns]:::action D -->|hnRNPs dominant| F[Skip exon 3<br/>Remove introns]:::action C --> G[Single mRNA isoform]:::outcome E --> H[mRNA isoform A]:::outcome F --> I[mRNA isoform B]:::outcome ``` ### Why Other Options Are Incorrect - **Option 0 (snRNPs):** Both constitutive and alternative splicing use the same core spliceosome snRNPs (U1, U2, U4, U5, U6). Alternative splicing involves *additional* regulatory proteins (SR proteins, hnRNPs), not different snRNPs. - **Option 2 (intron removal):** Both constitutive and alternative splicing remove introns. This is not a discriminator. - **Option 3 (GU-AG rule):** Both constitutive and alternative splicing follow the GU-AG rule at intron-exon boundaries. This is a universal rule, not specific to alternative splicing.